Evidence map›Paper›PMID 39537644›Full record

ArticleSchizophrenia (Heidelberg, Germany)2024

Parsing heterogeneity in global and local white matter integrity at different stages across the psychosis continuum.

Galya C Iseli, Sarah Ulrich, Philipp Stämpfli, Erich Studerus, David Coynel, Anita Riecher-Rössler, Philipp Homan, Stefan Kaiser, Stefan Borgwardt, Matthias Kirschner and 1 more

Abstract read
In one paragraph

Article in Schizophrenia (Heidelberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Galya C IseliUniversity of Basel, Department of Clinical Research (DKF), University Psychiatric Clinics (UPK), Translational Neurosciences, Basel, Switzerland. galya.iseli@unibas.ch.ORCID http://orcid.org/0000-0002-2038-7906
Sarah UlrichExperimental Cognitive and Clinical Affective Neuroscience (ECAN) Laboratory, Department of Clinical Research (DKF), Basel, Switzerland.ORCID http://orcid.org/0000-0002-1516-8362
Philipp StämpfliDepartment of Adult Psychiatry and Psychotherapy, University of Zurich, Zurich, Switzerland.
Erich StuderusDivision of Personality and Developmental Psychology, Department of Psychology, University of Basel, Basel, Switzerland.
David CoynelDivision of Cognitive Neuroscience, Department of Biomedicine, University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0001-5028-5807
Anita Riecher-RösslerMedical Faculty, University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0001-6361-8789
Philipp HomanDepartment of Adult Psychiatry and Psychotherapy, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-9034-148X
Stefan KaiserDivision of Adult Psychiatry, Department of Psychiatry, Geneva University Hospitals, Geneva, Switzerland.
Stefan BorgwardtTranslational Psychiatry, Department of Psychiatry and Psychotherapy, University of Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany.ORCID http://orcid.org/0000-0002-5792-3987
Matthias KirschnerDivision of Adult Psychiatry, Department of Psychiatry, Geneva University Hospitals, Geneva, Switzerland.ORCID http://orcid.org/0000-0002-9486-1439
André SchmidtUniversity of Basel, Department of Clinical Research (DKF), University Psychiatric Clinics (UPK), Translational Neurosciences, Basel, Switzerland.ORCID http://orcid.org/0000-0001-6055-8397

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 320030_200801
6 · The paper itself

Abstract

Psychosis progresses along a continuum. While heterogeneity is evident across the continuum, it remains unknown whether this is also reflected in white matter (WM) heterogeneity and whether parsing WM heterogeneity may reveal subgroups with more pronounced clinical features. This analysis included 212 participants consisting of healthy controls (HC, n = 59), individuals with high schizotypy (SPT, n = 27), at-risk mental state (ARMS, n = 35), and patients with first episode psychosis (FEP, n = 50) and schizophrenia (SZ, n = 41). Fractional anisotropy (FA) and mean diffusivity (MD) were derived from diffusion tensor imaging (DTI), and fibre density (FD), a non-tensor-derived diffusion marker, was computed. The Person-Based-Similarity Index (PBSI) and Coefficient of Variation Ratio (CVR) were computed to assess global and local heterogeneity. ANOVAs were performed to determine whether people with deviating PBSIs exhibit more pronounced clinical features. Global heterogeneity for all diffusion parameters significantly differed across groups, with greatest difference in heterogeneity between SZ and HC. Results further indicate that FA deviators exhibit lower global functioning and higher negative symptoms. Local FA heterogeneity was greater in FEP relative to ARMS and HC in almost all WM tracts, while SZ patients specifically showed greater heterogeneity in the right thalamic radiation and the left uncinate compared to HCs. Group differences in WM heterogeneity might be indicative of symptom specificity and duration. While these findings offer valuable insights into the neurobiological variability of psychosis, they are primarily hypothesis-generating. Future large-scale studies are warranted to test the robustness of diffusion markers and their clinical relevance.

Identifiers

PMID39537644
PMCPMC11561281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.